Sort
39,280 grants matching “leukemia”
DYSREGULATED NFKB PATHWAY SIGNALING IN MYELOPROLIFERATIVE NEOPLASMS
$413,675Stephen Tracy Oh · Washington University · R01 · FY2021 · HL
DYSREGULATED NFKB PATHWAY SIGNALING IN MYELOPROLIFERATIVE NEOPLASMS
$413,675Stephen Tracy Oh · Washington University · R01 · FY2022 · HL
DYSREGULATED NFKB PATHWAY SIGNALING IN MYELOPROLIFERATIVE NEOPLASMS
$413,675Stephen Tracy Oh · Washington University · R01 · FY2019 · HL
DYSREGULATED NFKB PATHWAY SIGNALING IN MYELOPROLIFERATIVE NEOPLASMS
$413,675Stephen Tracy Oh · Washington University · R01 · FY2020 · HL
A model of myelodysplastic syndrome progression and leukemic stem cells
$413,624Yupo Ma · State University New York Stony Brook · R01 · FY2012 · HL
Artemis: Biochemical ,structural and functional analysis
$413,590Patricia Cortes · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · AI
Roles of Glycoslyation in Notch Signaling
$413,532Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2007 · CA
The role and mechanism of FTO in leukemogenesis and drug response
$413,529Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies
$413,526Gianpietro Dotti · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
TET2-mediated transcriptional and epigenetic control of normal and malignant hematopoiesis
$413,488Mingjiang Xu · University Of Texas Hlth Science Center · R01 · FY2021 · HL
Patterns of immune response in COVID-19 patients
$413,425Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Computational methods to identify neo-TADs and enhancer-hijacking in rearranged genomes
$413,358Feng Yue · Northwestern University At Chicago · R01 · FY2021 · HG
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$413,325Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · AI
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$413,325Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · AI
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$413,325Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · AI
Exploring oncogenic translation programs in cancer
$413,319Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Genetic Basis of Myeloid Neoplasia--Mutagenesis Screens
$413,300Dana-Farber Cancer Institute · R01 · FY2005 · CA
Genetic Basis of Myeloid Neoplasia--Mutagenesis Screens
$413,300Dana-Farber Cancer Institute · R01 · FY2004 · CA
Genetic Basis of Myeloid Neoplasia--Mutagenesis Screens
$413,300Dana-Farber Cancer Institute · R01 · FY2003 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$413,286Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Transfusion of Donor Effector Memory T Cells for GVL and Immune Reconstitution
$413,278Mark J Shlomchik · Yale University · R01 · FY2011 · HL
Characterizing the MSI2 network in leukemia
$413,245Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Characterizing the MSI2 network in leukemia
$413,245Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype
$413,163Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2021 · CA
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer
$413,124Frederic D Bushman · University Of Pennsylvania · R01 · FY2014 · AI